Johns Hopkins Study shows impact of CDC funding cuts on HIV rates across the U.S.
Research from Johns Hopkins Medicine indicates that reducing CDC HIV testing funding could lead to a 10% increase in new infections by 2030, with Louisiana being most affected, highlighting the importance of sustained testing efforts.
Johns Hopkins Medicine researchers anticipate a rise in human immunodeficiency virus (HIV) prevalence if Centers for Disease Control and Prevention (CDC) testing funding were to be reduced, according to an announcement.
The researchers conducted a study investigating what a funding disturbance would mean for 18 U.S. states. They utilized a computer model for their analysis of multiple scenarios. Key findings:
A funding interference could lead to a 10% jump in infections, or about 12,000 more by 2030.
The authors concluded, “Disruptions to CDC-funded HIV testing would substantially increase new infections, particularly in states with more rural epidemics. These findings demonstrate the value of the CDC's HIV testing activities in curbing the spread of HIV in the United States.”
